MSFT   214.08 (+0.59%)
GOOGL   1,518.83 (+1.01%)
AMZN   3,179.06 (+3.18%)
NVDA   420.51 (+2.90%)
CGC   16.06 (-1.65%)
GE   6.60 (-3.79%)
TSLA   1,394.72 (+2.11%)
AMD   57.24 (+7.11%)
T   29.51 (-3.12%)
ACB   11.71 (-3.70%)
GILD   74.76 (-1.12%)
DIS   116.72 (+0.05%)
BAC   22.75 (-1.56%)
BA   173.54 (-3.63%)
MSFT   214.08 (+0.59%)
GOOGL   1,518.83 (+1.01%)
AMZN   3,179.06 (+3.18%)
NVDA   420.51 (+2.90%)
CGC   16.06 (-1.65%)
GE   6.60 (-3.79%)
TSLA   1,394.72 (+2.11%)
AMD   57.24 (+7.11%)
T   29.51 (-3.12%)
ACB   11.71 (-3.70%)
GILD   74.76 (-1.12%)
DIS   116.72 (+0.05%)
BAC   22.75 (-1.56%)
BA   173.54 (-3.63%)
MSFT   214.08 (+0.59%)
GOOGL   1,518.83 (+1.01%)
AMZN   3,179.06 (+3.18%)
NVDA   420.51 (+2.90%)
CGC   16.06 (-1.65%)
GE   6.60 (-3.79%)
TSLA   1,394.72 (+2.11%)
AMD   57.24 (+7.11%)
T   29.51 (-3.12%)
ACB   11.71 (-3.70%)
GILD   74.76 (-1.12%)
DIS   116.72 (+0.05%)
BAC   22.75 (-1.56%)
BA   173.54 (-3.63%)
MSFT   214.08 (+0.59%)
GOOGL   1,518.83 (+1.01%)
AMZN   3,179.06 (+3.18%)
NVDA   420.51 (+2.90%)
CGC   16.06 (-1.65%)
GE   6.60 (-3.79%)
TSLA   1,394.72 (+2.11%)
AMD   57.24 (+7.11%)
T   29.51 (-3.12%)
ACB   11.71 (-3.70%)
GILD   74.76 (-1.12%)
DIS   116.72 (+0.05%)
BAC   22.75 (-1.56%)
BA   173.54 (-3.63%)
Log in

NYSE:CLNYColony Capital Stock Price, Forecast & News

$2.27
-0.07 (-2.99 %)
(As of 07/9/2020 03:56 PM ET)
Add
Compare
Today's Range
$2.23
Now: $2.27
$2.39
50-Day Range
$1.77
MA: $2.43
$3.10
52-Week Range
$1.33
Now: $2.27
$6.14
Volume169,805 shs
Average Volume7.22 million shs
Market Capitalization$1.09 billion
P/E RatioN/A
Dividend Yield19.30%
Beta1.86
Colony Capital, Inc. (NYSE: CLNY) is a leading global investment management firm with assets under management of $43 billion. The Company manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded real estate investment trusts and registered investment companies. The Company has significant holdings in: (a) the healthcare, industrial and hospitality property sectors; (b) Colony Credit Real Estate, Inc. (NYSE: CLNC) and NorthStar Realty Europe Corp. (NYSE: NRE), which are both externally managed by subsidiaries of the Company; and (c) various other equity and debt investments. The Company is headquartered in Los Angeles with key offices in New York, Paris and London, and has over 400 employees across 17 locations in ten countries.
Read More
Colony Capital logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.98 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustryMortgage REITs
SectorFinance
CUSIP19624R10
Phone310-282-8820

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.33 billion
Book Value$16.25 per share

Profitability

Net Income$-1,048,810,000.00

Miscellaneous

Employees400
Market Cap$1.09 billion
Next Earnings Date8/14/2020 (Estimated)
OptionableOptionable

Receive CLNY News and Ratings via Email

Sign-up to receive the latest news and ratings for CLNY and its competitors with MarketBeat's FREE daily newsletter.

Colony Capital (NYSE:CLNY) Frequently Asked Questions

How has Colony Capital's stock been impacted by COVID-19 (Coronavirus)?

Colony Capital's stock was trading at $2.97 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CLNY stock has decreased by 23.6% and is now trading at $2.27. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Colony Capital?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colony Capital in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Colony Capital.

When is Colony Capital's next earnings date?

Colony Capital is scheduled to release its next quarterly earnings announcement on Friday, August 14th 2020. View our earnings forecast for Colony Capital.

How were Colony Capital's earnings last quarter?

Colony Capital Inc (NYSE:CLNY) posted its quarterly earnings data on Friday, May, 8th. The real estate investment trust reported ($0.76) EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.04 by $0.80. The real estate investment trust earned $32.87 million during the quarter, compared to analysts' expectations of $31.40 million. Colony Capital had a negative net margin of 57.57% and a negative return on equity of 33.82%. View Colony Capital's earnings history.

How often does Colony Capital pay dividends? What is the dividend yield for Colony Capital?

Colony Capital announced a quarterly dividend on Monday, March 2nd. Investors of record on Tuesday, March 31st will be given a dividend of $0.11 per share on Wednesday, April 15th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 19.38%. The ex-dividend date is Monday, March 30th. View Colony Capital's dividend history.

What price target have analysts set for CLNY?

1 equities research analysts have issued twelve-month price targets for Colony Capital's stock. Their forecasts range from $4.00 to $4.00. On average, they expect Colony Capital's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 76.2% from the stock's current price. View analysts' price targets for Colony Capital.

Has Colony Capital been receiving favorable news coverage?

News coverage about CLNY stock has trended negative this week, according to InfoTrie. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Colony Capital earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news coverage about the real estate investment trust a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Colony Capital.

Are investors shorting Colony Capital?

Colony Capital saw a increase in short interest in June. As of June 30th, there was short interest totaling 12,370,000 shares, an increase of 54.8% from the June 15th total of 7,990,000 shares. Based on an average daily trading volume, of 6,650,000 shares, the short-interest ratio is currently 1.9 days. Approximately 2.6% of the shares of the stock are sold short. View Colony Capital's Current Options Chain.

Who are some of Colony Capital's key competitors?

What other stocks do shareholders of Colony Capital own?

Who are Colony Capital's key executives?

Colony Capital's management team includes the following people:
  • Mr. Thomas Joseph Barrack Jr., Founder, Exec. Chairman & CEO (Age 70)
  • Mr. Darren J. Tangen, Pres (Age 48)
  • Mr. Kevin P. Traenkle, Exec. VP & Chief Investment Officer (Age 49)
  • Mr. Mark Melvin Hedstrom CPA, Exec. VP, COO & CFO (Age 60)
  • Mr. Neale W. Redington, MD & Chief Accounting Officer (Age 52)

What is Colony Capital's stock symbol?

Colony Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLNY."

Who are Colony Capital's major shareholders?

Colony Capital's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Corrado Advisors LLC (0.01%). Company insiders that own Colony Capital stock include Craig M Hatkoff, Dale Anne Reiss, Neale Redington, Raymond C Mikulich and Thomas Barrack Jr. View institutional ownership trends for Colony Capital.

Which institutional investors are buying Colony Capital stock?

CLNY stock was purchased by a variety of institutional investors in the last quarter, including Corrado Advisors LLC. Company insiders that have bought Colony Capital stock in the last two years include Craig M Hatkoff, Raymond C Mikulich, and Thomas Barrack Jr. View insider buying and selling activity for Colony Capital.

How do I buy shares of Colony Capital?

Shares of CLNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Colony Capital's stock price today?

One share of CLNY stock can currently be purchased for approximately $2.27.

How big of a company is Colony Capital?

Colony Capital has a market capitalization of $1.09 billion and generates $2.33 billion in revenue each year. The real estate investment trust earns $-1,048,810,000.00 in net income (profit) each year or $0.50 on an earnings per share basis. Colony Capital employs 400 workers across the globe.

What is Colony Capital's official website?

The official website for Colony Capital is www.clny.com.

How can I contact Colony Capital?

Colony Capital's mailing address is 515 SOUTH FLOWER STREET 44TH FLOOR, LOS ANGELES CA, 90071. The real estate investment trust can be reached via phone at 310-282-8820 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.